Your browser doesn't support javascript.
loading
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.
Reid, Tony; Oronsky, Bryan; Scicinski, Jan; Scribner, Curt L; Knox, Susan J; Ning, Shoucheng; Peehl, Donna M; Korn, Ron; Stirn, Meaghan; Carter, Corey A; Oronsky, Arnold; Taylor, Michael J; Fitch, William L; Cabrales, Pedro; Kim, Michelle M; Burris, Howard A; Lao, Christopher D; Abrouk, Nacer E D; Fanger, Gary R; Infante, Jeffrey R.
Afiliación
  • Reid T; Moores Cancer Center, University of California and San Diego, La Jolla, CA, USA. Electronic address: tonyreid@ucsd.edu.
  • Oronsky B; EpicentRx, Mountain View, CA, USA.
  • Scicinski J; EpicentRx, Mountain View, CA, USA.
  • Scribner CL; RRD International, Rockville, MD, USA.
  • Knox SJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Ning S; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Peehl DM; Department of Urology, Stanford University, Stanford, CA, USA.
  • Korn R; Imaging Endpoints, Scottsdale, AZ, USA.
  • Stirn M; EpicentRx, Mountain View, CA, USA.
  • Carter CA; Walter Reed National Military Medical Center, Bethesda, MD, USA.
  • Oronsky A; InterWest Partners, Menlo Park, CA, USA.
  • Taylor MJ; NonClinical Safety Assessment, Mountain View, CA, USA.
  • Fitch WL; Stanford University School of Medicine, Stanford, CA, USA.
  • Cabrales P; Department of Bioengineering, University of California and San Diego, La Jolla, CA, USA.
  • Kim MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Burris HA; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA.
  • Lao CD; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Abrouk NED; Innovexe, Mountain View, CA, USA.
  • Fanger GR; EpicentRx, Mountain View, CA, USA.
  • Infante JR; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA.
Lancet Oncol ; 16(9): 1133-1142, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26296952
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azetidinas / Epigénesis Genética / Neoplasias / Nitrocompuestos Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azetidinas / Epigénesis Genética / Neoplasias / Nitrocompuestos Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article